Abstract:In forex trading, what truly determines risk is often not market volatility itself, but whether information is authentic, transparent, and fully visible.

In forex trading, what truly determines risk is often not market volatility itself, but whether information is authentic, transparent, and fully visible. A single real trading experience or an objective broker review can serve as a crucial reference point, helping other investors avoid risks and make informed decisions.
As a leading global forex ecosystem service platform, WikiFX has consistently upheld a fact-based approach—providing industry information services for forex investors and practitioners, helping investors reduce trading risks, safeguard their rights, enhance industry transparency, and promote self-regulation.
To further improve transparency and standardization in the forex industry, promote a more regulated market environment, and reduce the occurrence of misconduct and fraud, WikiFX officially launches the broker review initiative, “Every Review Counts.”
As WikiFXs annual “March 15 Forex Rights Protection Day” approaches, we sincerely invite forex investors worldwide to join the Every Review Counts co-creation initiative.
Through every authentic post and shared experience, you contribute credible information to the forex industry—helping fill one of the most critical yet often overlooked gaps in market transparency.
You may choose to share:
WikiFX firmly believes that every genuine review deserves to be seen.
For investors who submit rights-protection exposure reports, we will stand with you—publicly exposing illegal or non-compliant broker practices and pushing brokers to acknowledge and properly address complaints.
During this campaign, outstanding contributions may receive:
Join now: https://www.wikifxact.com/en/review/
Throughout the campaign period, WikiFX will also release:
WikiFX will work alongside global investors and industry professionals to foster a fairer, safer, and more transparent market environment.
We believe that true industry progress is not driven by slogans, but by evidence collection, public disclosure, and authentic reviews—leaving risks nowhere to hide. Rights protection is not only about exposing problems, but also about ensuring that truly compliant and transparent brokers are recognized.
Your single honest share may be the critical step that helps others avoid risk.
Join the “Every Review Counts” broker review initiative today.


Have you had to encounter numerous denials on fund withdrawals by KapitalRS, a Serbia-based CFD broker? Were you asked to pay additional fees for withdrawal access? Did you incur losses on your forex positions due to the confusion concerning the bonus? Does your overall trading cost go up due to the wide spreads charged by the forex broker? These issues have arguably become the highlight on several broker review platforms. In this KapitalRS article, we have elaborated on numerous complaints against the brokerage firm. Take a look!

Trive, a Netherlands-based leading CFD broker across forex, stocks, indices and commodities, is facing ire from its employees on the unpaid salary crisis that has haunted them for four months starting from November 2025. Upset over such a long delay, employees have been using social media platforms to express their frustration. Read on for more revelation.

Did you have a good trading experience with LONG ASIA initially before it went bad, as you sought fund withdrawals from the platform? Did Saint Vincent and the Grenadines-based forex brokerage house deny you access to funds despite numerous withdrawal requests? Have you lost your funds because of this denial? Failing to log in despite numerous attempts? You are not alone! Many traders have accused the broker of these trading practices. In this LONG ASIA review article, we have highlighted some complaints against the broker. Read on as we share all these details with you.

The Financial Industry Regulatory Authority (FINRA) has filed a formal complaint against Spartan Capital Securities LLC, its CEO John Dennis Lowry, and its former Chief Compliance Officer (CCO) Kim Marie Monchik. The Department of Enforcement alleges a sophisticated scheme to defraud customers during a pharmaceutical company’s initial public offering (IPO), resulting in over $50 million in profits for the firm and its insiders while customers were left with dramatic losses.